Severe Bleeding due to Factor V Inhibitor after Repeated Operations Using Fibrin Sealant Containing Bovine Thrombin

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Facebook Linkedin Weibo

Thromb Haemost 1997; 77(06): 1223
DOI: 10.1055/s-0038-1656146

Letters to the Editor

Schattauer GmbH Stuttgart

W Muntean

¹Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria

,

W Zenz

¹Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria

,

G Edlinger

¹Department of Pediatrics, Divs.of General Pediatrics, University of Graz, Austria

,

A Beitzke

²Department of Pediatrics, Divs.of Pediatric Cardiology, University of Graz, Austria

Weitere Informationen

Publikationsverlauf

Received 27. Januar 1997

Accepted after revision 06. März 1997

Publikationsdatum:
12. Juli 2018 (online)

References
1 Carrol JF, Moskowitz KA, Edwards NM, Hickley TJ, Rose EA, Budzynski AZ. Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent. Thromb Haemost 1996; 76: 925-931

MissingFormLabel
Thieme Connect PubMed Suche in Google Scholar
2 Zehnder JL, Leung LLK. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 1990; 76: 2011-2016

MissingFormLabel
PubMed Suche in Google Scholar
3 Muntean W, Zenz W, Finding K, Zobel G, Beitzke A. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Pediatr 1994; 84: 84-87

MissingFormLabel
PubMed Suche in Google Scholar